BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26415585)

  • 1. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
    Kiel MJ; Sahasrabuddhe AA; Rolland DCM; Velusamy T; Chung F; Schaller M; Bailey NG; Betz BL; Miranda RN; Porcu P; Byrd JC; Medeiros LJ; Kunkel SL; Bahler DW; Lim MS; Elenitoba-Johnson KSJ
    Nat Commun; 2015 Sep; 6():8470. PubMed ID: 26415585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
    Laurent C; Nicolae A; Laurent C; Le Bras F; Haioun C; Fataccioli V; Amara N; Adélaïde J; Guille A; Schiano JM; Tesson B; Traverse-Glehen A; Chenard MP; Mescam L; Moreau A; Chassagne-Clement C; Somja J; Escudié F; André M; Martin N; Lacroix L; Lemonnier F; Hamy AS; Reyal F; Bannier M; Oberic L; Prade N; Frénois FX; Beldi-Ferchiou A; Delfau-Larue MH; Bouabdallah R; Birnbaum D; Brousset P; Xerri L; Gaulard P
    Blood; 2020 Jan; 135(5):360-370. PubMed ID: 31774495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.
    Woollard WJ; Pullabhatla V; Lorenc A; Patel VM; Butler RM; Bayega A; Begum N; Bakr F; Dedhia K; Fisher J; Aguilar-Duran S; Flanagan C; Ghasemi AA; Hoffmann RM; Castillo-Mosquera N; Nuttall EA; Paul A; Roberts CA; Solomonidis EG; Tarrant R; Yoxall A; Beyers CZ; Ferreira S; Tosi I; Simpson MA; de Rinaldis E; Mitchell TJ; Whittaker SJ
    Blood; 2016 Jun; 127(26):3387-97. PubMed ID: 27121473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing.
    Andersson E; Eldfors S; Edgren H; Ellonen P; Väkevä L; Ranki A; Mustjoki S
    Exp Dermatol; 2014 May; 23(5):366-8. PubMed ID: 24689486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
    Lee S; Park HY; Kang SY; Kim SJ; Hwang J; Lee S; Kwak SH; Park KS; Yoo HY; Kim WS; Kim JI; Ko YH
    Oncotarget; 2015 Jul; 6(19):17764-76. PubMed ID: 25980440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights Into the Complex Mutational Landscape of Sézary Syndrome.
    Mirza AS; Horna P; Teer JK; Song J; Akabari R; Hussaini M; Sokol L
    Front Oncol; 2020; 10():514. PubMed ID: 32373524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
    Kiel MJ; Velusamy T; Rolland D; Sahasrabuddhe AA; Chung F; Bailey NG; Schrader A; Li B; Li JZ; Ozel AB; Betz BL; Miranda RN; Medeiros LJ; Zhao L; Herling M; Lim MS; Elenitoba-Johnson KS
    Blood; 2014 Aug; 124(9):1460-72. PubMed ID: 24825865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.
    Tiacci E; Ladewig E; Schiavoni G; Penson A; Fortini E; Pettirossi V; Wang Y; Rosseto A; Venanzi A; Vlasevska S; Pacini R; Piattoni S; Tabarrini A; Pucciarini A; Bigerna B; Santi A; Gianni AM; Viviani S; Cabras A; Ascani S; Crescenzi B; Mecucci C; Pasqualucci L; Rabadan R; Falini B
    Blood; 2018 May; 131(22):2454-2465. PubMed ID: 29650799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent Mutations in Natural Killer/T Cell Lymphoma.
    Zhang Y; Li C; Xue W; Zhang M; Li Z
    Cell Physiol Biochem; 2018; 49(1):1-16. PubMed ID: 30134235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
    Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
    Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.
    Pike KA; Tremblay ML
    Cytokine; 2016 Jun; 82():52-7. PubMed ID: 26817397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.
    Nairismägi ML; Tan J; Lim JQ; Nagarajan S; Ng CC; Rajasegaran V; Huang D; Lim WK; Laurensia Y; Wijaya GC; Li ZM; Cutcutache I; Pang WL; Thangaraju S; Ha J; Khoo LP; Chin ST; Dey S; Poore G; Tan LH; Koh HK; Sabai K; Rao HL; Chuah KL; Ho YH; Ng SB; Chuang SS; Zhang F; Liu YH; Pongpruttipan T; Ko YH; Cheah PL; Karim N; Chng WJ; Tang T; Tao M; Tay K; Farid M; Quek R; Rozen SG; Tan P; Teh BT; Lim ST; Tan SY; Ong CK
    Leukemia; 2016 Jun; 30(6):1311-9. PubMed ID: 26854024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
    López C; Bergmann AK; Paul U; Murga Penas EM; Nagel I; Betts MJ; Johansson P; Ritgen M; Baumann T; Aymerich M; Jayne S; Russell RB; Campo E; Dyer MJ; Dürig J; Siebert R
    Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.
    Liu Z; Filip I; Gomez K; Engelbrecht D; Meer S; Lalloo PN; Patel P; Perner Y; Zhao J; Wang J; Pasqualucci L; Rabadan R; Willem P
    Blood Cancer Discov; 2020 Jul; 1(1):112-125. PubMed ID: 33225311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The JAK/STAT signaling cascade in gastric carcinoma (Review).
    Khanna P; Chua PJ; Bay BH; Baeg GH
    Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine.
    Chevret E; Merlio JP
    J Invest Dermatol; 2016 Jul; 136(7):1319-1324. PubMed ID: 27342034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of JAK-STAT signaling pathway genes and their microRNAs in the intestinal mucosa of genetically disparate chicken lines induced with necrotic enteritis.
    Truong AD; Rengaraj D; Hong Y; Hoang CT; Hong YH; Lillehoj HS
    Vet Immunol Immunopathol; 2017 May; 187():1-9. PubMed ID: 28494922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays.
    Caprini E; Cristofoletti C; Arcelli D; Fadda P; Citterich MH; Sampogna F; Magrelli A; Censi F; Torreri P; Frontani M; Scala E; Picchio MC; Temperani P; Monopoli A; Lombardo GA; Taruscio D; Narducci MG; Russo G
    Cancer Res; 2009 Nov; 69(21):8438-46. PubMed ID: 19843862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL.
    Wahnschaffe L; Braun T; Timonen S; Giri AK; Schrader A; Wagle P; Almusa H; Johansson P; Bellanger D; López C; Haferlach C; Stern MH; Dürig J; Siebert R; Mustjoki S; Aittokallio T; Herling M
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.